Bard1 Life Sciences

A leading Australian-based medical diagnostics company with an innovative cancer diagnostics portfolio.
Bard1 Life Sciences
Operating

BARD1 Life Sciences Ltd (ASX:BD1) (BARD1 or the Company) is a leading Australian-based medical diagnostics company with an innovative portfolio of diagnostic technologies and products. The Company is focused on the development and commercialisation of best in class lifesaving diagnostic solutions for health care professionals and patients. The cancer diagnostics portfolio includes the marketed hTERT test to aid in the diagnosis of bladder cancer and tests in development for ovarian, breast, lung, prostate and pancreatic cancers.

Accelerators
2019 (Life Sciences)
Accelerator

SBE Australia

Images
Taken on 2021-01
Blog Posts
2nd November, 2016
News Article

 Location
Melbourne
 Links
 People
 Tags
#biomedicine
#biotech
#diagnostics
#medical research
 Feedback